Literature DB >> 3812449

Prevalence of Alzheimer's disease in a retirement community.

R I Pfeffer, A A Afifi, J M Chance.   

Abstract

In a white, predominantly middle class southern California retirement community, 817 adults aged 65-99 years were evaluated in 1980-1982 in a study designed to assess prevalence of early Alzheimer-type senile dementia. Based on 162 neurologically diagnosed cases, the age- and sex-adjusted prevalence of Alzheimer's disease in the target population was 15.3% (95% confidence interval = 13.0-17.5) among persons aged 65+ years and 35.8% among persons aged 80+ years. Age-adjusted correction for false negatives not detected by a screening procedure yields an estimated prevalence of 16.4% in persons aged 65+ years. Validity of the diagnostic approach was confirmed by a follow-up study. These rates far exceed past prevalence estimates for this disease. Since prevalence of mid- or later stages of Alzheimer's disease may have been underestimated, the high rates in this study may reflect a considerable community burden of early disease. Observed prevalence of Alzheimer-type senile dementia was higher among men than women after adjustment for age, 19.1% and 13.1%, respectively. The female predominance reported in many past clinical surveys may be peculiar to late disease and reflect care-seeking and care-utilization behaviors, rather than differences in incidence.

Entities:  

Mesh:

Year:  1987        PMID: 3812449     DOI: 10.1093/oxfordjournals.aje.a114548

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  20 in total

1.  Incidence and risk factors for cognitive impairment no dementia and mild cognitive impairment in African Americans.

Authors:  Frederick W Unverzagt; Adesola Ogunniyi; Vanessa Taler; Sujuan Gao; Kathleen A Lane; Olusegun Baiyewu; Oye Gureje; Valerie Smith-Gamble; Ann Hake; Hugh C Hendrie; Kathleen S Hall
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Jan-Mar       Impact factor: 2.703

2.  The PREMAP Study: prevalence and risk factors of dementia and clinically diagnosed Alzheimer's disease in Provence, France. Prevalence of Alzheimer's Disease in Provence.

Authors:  Y Obadia; M Rotily; A Degrand-Guillaud; J Guelain; M Ceccaldi; C Severo; M Poncet; A Alperovitch
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

3.  Protease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease.

Authors:  S L Wagner; J W Geddes; C W Cotman; A L Lau; D Gurwitz; P J Isackson; D D Cunningham
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

4.  Identification of dementia: agreement among national survey data, medicare claims, and death certificates.

Authors:  Truls Ostbye; Donald H Taylor; Elizabeth C Clipp; Lynn Van Scoyoc; Brenda L Plassman
Journal:  Health Serv Res       Date:  2008-02       Impact factor: 3.402

Review 5.  The epidemiology of dementia in North America.

Authors:  M R Eastwood; S L Rifat; D Roberts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

6.  Synthesis and in silico evaluation of 1N-methyl-1S-methyl-2-nitroethylene (NMSM) derivatives against Alzheimer disease: to understand their interacting mechanism with acetylcholinesterase.

Authors:  M Kannan; P Manivel; K Geetha; J Muthukumaran; H Surya Prakash Rao; R Krishna
Journal:  J Chem Biol       Date:  2012-09-20

Review 7.  The older driver--a review.

Authors:  R Morgan; D King
Journal:  Postgrad Med J       Date:  1995-09       Impact factor: 2.401

8.  Epidemiology of Alzheimer's presenile dementia in Scotland, 1974-88.

Authors:  G McGonigal; B Thomas; C McQuade; J M Starr; W J MacLennan; L J Whalley
Journal:  BMJ       Date:  1993-03-13

9.  Cognitive impairment and hospital use.

Authors:  P G Weiler; J E Lubben; I Chi
Journal:  Am J Public Health       Date:  1991-09       Impact factor: 9.308

Review 10.  Mild cognitive dysfunction: an epidemiological perspective with an emphasis on African Americans.

Authors:  Frederick W Unverzagt; Kathleen A Lane; Christopher Callahan; Adesola Ogunniyi; Olusegun Baiyewu; Oye Gureje; Kathleen S Hall; Hugh C Hendrie
Journal:  J Geriatr Psychiatry Neurol       Date:  2007-12       Impact factor: 2.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.